Bank of New York Mellon »

Ani Pharmaceuticals shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Ani Pharmaceuticals shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Ani Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ani Pharmaceuticals held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ani Pharmaceuticals by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2025-09-30 $984k 700k 1.41

More positions owned by Bank of New York Mellon

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Inc-class A Cl A (META)
Broadcom (AVGO)
Ishares Core S&p 500 Etf Core (IVV)
Alphabet Cl A (GOOGL)
Alphabet CL C (GOOG)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Berkshire Hathaway Inc-cl B CL B (BRK.B)
Exxon Mobil Corporation (XOM)
Mastercard Inc - A Cl A (MA)
Johnson & Johnson (JNJ)

View all positions for Bank of New York Mellon

Top funds holding Ani Pharmaceuticals

Linden Advisors
Camden Asset Management
BlackRock
Empyrean Capital Partners
Millennium Management
Citadel Advisors
Absolute Investment Advisers
Jpmorgan Chase & Co
Lazard Asset Management
Polar Securities
Universal- Beteiligungs- und Servicegesellschaft mbH
Gabelli Funds
Leucadia National Corporation
Picton Mahoney Asset Management
FMR

View all funds holding Ani Pharmaceuticals